Variations in C-reactive protein during a single haemodialysis session do not associate with mortality

Nephrology Dialysis Transplantation

Volumn 25, Issue 11, 2010, Pages 3717-3723

  Meuwese, Christiaan L ^a,b   Halbesma, Nynke ^a   Stenvinkel, Peter ^b   Dekker, Friedo W ^a   Molanaei, Hadi ^b   Qureshi, Abdul R ^b   Barany, Peter ^b   Heimburger, Olof ^b   Lindholm, Bengt ^b   Krediet, Raymond T ^c   Boeschoten, Els W ^d   Carrero, Juan Jesús ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d Hans Mak Institute   (Netherlands)

Author keywords

C reactive protein; Chronic kidney disease; Hemodialysis; Inflammatory response; Mortality

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY;

ADULT; AGED; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS;

EID: 79952138969     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq273     Document Type: Article

References (36)

1. de Jager DJ, Grootendorst DC, Jager KJ et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302: 1782-1789
2. Tripepi G, Mallamaci F, Zoccali C. Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: Searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 2005; 16: S83-S88 (Pubitemid 41725091)
3. Zoccali C, Tripepi G, Mallamaci F. Dissecting inflammation in ESRD: Do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients? J Am Soc Nephrol 2006; 17: S169-S173 (Pubitemid 44865244)
4. Stenvinkel P, Lindholm B. C-reactive protein in end-stage renal disease: Are there reasons to measure it? Blood Purif 2005; 23: 72-78 (Pubitemid 40082247)
5. Carrero JJ, Yilmas MI, Lindholm B et al. Kidney disease: How can we treat it? Blood Purif 2008; 26: 291-299
6. Yilmaz MI, Carrero JJ, Axelsson J et al. Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: Sources and consequences. Clin Nephrol 2007; 68: 1-9 (Pubitemid 47045486)
7. Caglar K, Peng Y, Pupim LB et al. Inflammatory signals associated with hemodialysis. Kidney Int 2002; 62: 1408-1416
8. Raj DS, Dominic EA,Wolfe R et al. Coordinated increase in albumin, fibrinogen, and muscle protein synthesis during hemodialysis: Role of cytokines. Am J Physiol Endocrinol Metab 2004; 286: E658-E664 (Pubitemid 38374965)
9. Ikizler TA, Pupim LB, Brouillette JR et al. Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Endocrinol Metab 2002; 282: E107-E116 (Pubitemid 34654113)
10. Raj DS, Moseley P, Dominic EA et al. Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis. Kidney Int 2008; 73: 1054-1061 (Pubitemid 351543904)
11. Carrero JJ, Chmielewski M, Axelsson J et al. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. Clin Nutr 2008; 27: 557-564
12. Carrero JJ, Park SH, Axelsson J et al. Cytokines, atherogenesis, and hypercatabolism in chronic kidney disease: A dreadful triad. Semin Dial 2009; 22: 381-386
13. Korevaar JC, van Manen JG, Dekker FW et al. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. J Am Soc Nephrol 2004; 15: 2916-2922 (Pubitemid 41103401)
14. Schulze C, Conrad N, Schutz A et al. Reduced expression of systemic proinflammatory cytokines after off-pump versus conventional coronary artery bypass grafting.Thorac Cardiovasc Surg 2000; 48:364-369 (Pubitemid 32004947)
15. Kaysen GA, Dubin JA, Muller HG et al. The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group. Kidney Int 2000; 58: 346-352 (Pubitemid 30429881)
16. van Tellingen A, Grooteman MP, Schoorl M et al. Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int 2002; 62: 632-638 (Pubitemid 34779778)
17. Snaedal S, Heimburger O, Qureshi AR et al. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: Implications for patient survival. Am J Kidney Dis 2009; 53: 1024-1033
18. Carrero JJ, Qureshi AR, Axelsson J et al. Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr 2007; 85: 695-701 (Pubitemid 46393499)
19. Termorshuizen F, Korevaar JC, Dekker FW et al. Hemodialysis and peritoneal dialysis: Comparison of adjusted mortality rates according to the duration of dialysis: Analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 2003; 14: 2851-2860 (Pubitemid 37305648)
20. Davies SJ, Phillips L, Naish PF et al. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant 2002; 17: 1085-1092 (Pubitemid 34746213)
21. de Mutsert R, Grootendorst DC, Boeschoten EW et al. Subjective global assessment of nutritional status is strongly associated with mortality in chronic dialysis patients. Am J Clin Nutr 2009; 89: 787-793
22. Grootendorst DC, de Jager DJ, Brandenburg VM et al. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients-no additional power for mortality prediction with high-sensitivity CRP. Nephrol Dial Transplant 2007; 22: 3277-3284 (Pubitemid 350202555)
23. Bergstrom J, Wehle B. No change in corrected beta 2-microglobulin concentration after cuprophane haemodialysis. Lancet 1987; 1: 628-629 (Pubitemid 17024248)
24. Koulouridis E, Tzilianos M, Katsarou A et al. Homocysteine and Creactive protein levels in haemodialysis patients. Int Urol Nephrol 2001; 33: 207-215 (Pubitemid 34575368)
25. Ciaccio M, Bivona G, Di SR et al. Changes in serum fetuin-A and inflammatory markers levels in end-stage renal disease (ESRD): Effect of a single session haemodialysis. Clin Chem Lab Med 2008; 46: 212-214
26. Park CW, Shin YS, Kim CM et al. Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis 2002; 40: 1230-1239 (Pubitemid 35403135)
27. Wanner C, Metzger T. C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant 2002; 17: 29-32 (Pubitemid 34918876)
28. Baigrie RJ, Lamont PM, Kwiatkowski D et al. Systemic cytokine response after major surgery. Br J Surg 1992; 79: 757-760
29. Calabro P, ChangDW,Willerson JTet al. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: Linking obesity to vascular inflammation. J Am Coll Cardiol 2005; 46: 1112-1113 (Pubitemid 41316523)
30. Paivaniemi OE, Maasilta PK, Vainikka TL et al. Local C-reactive protein expression in obliterative lesions and the bronchial wall in posttransplant obliterative bronchiolitis. Mediators Inflamm 2009; 2009: 510254
31. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91: 1351-1357 (Pubitemid 23127332)
32. Casas JP, Shah T, Hingorani AD et al. C-reactive protein and coronary heart disease: A critical review. J Intern Med 2008; 264: 295-314
33. Fujimori A, Naito H, Miyazaki T. Adsorption of complement, cytokines, and proteins by different dialysis membrane materials: Evaluation by confocal laser scanning fluorescence microscopy. Artif Organs 1998; 22: 1014-1017 (Pubitemid 28564157)
34. Lindsay RM, Shulman T, Prakash S et al. Hemodynamic and volume changes during hemodialysis. Hemodial Int 2003; 7: 204-208
35. Boehme M, Kaehne F, Kuehne A et al. Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease. Nephrol Dial Transplant 2007; 22: 2224-2229 (Pubitemid 47244700)
36. Friedrich B, Alexander D, Janessa A et al. Acute effects of hemodialysis on cytokine transcription profiles: Evidence for C-reactive protein-dependency of mediator induction. Kidney Int 2006; 70: 2124-2130 (Pubitemid 44871375)